MSH|^~\&|LAB|SMH|||201910291133||ORU^R01|4092767|D|2.3|||AL|NE
PID|1||SM00044280|SM44111|LABTEST^AIR^PRESTO||19870323|M||||||||||SM005225/18|9875450974
OBR|1|34613^LAB|00026599^2710:CE00001R^LAB^271019:CE1^34613|500.3040^TPMTREQ^TPMT RBC Activity PhenoRequest^^XXX-3270^XXX-3270||201910291040|201910270900|||||||201910270930||||||||||LAB|F||||
OBX|1|ST|500.3040^TPMTREQ^TPMT RBC Activity PhenoRequest^^XXX-3270^XXX-3270|1|Approved^^N|||N||A^S|F|||201910291040
OBR|2|34613^LAB|00026599^2710:CE00001R^LAB^271019:CE1^34613|500.3050^TPMT^TPMT RBC Enzyme Activity Pheno^^^21563-2||201910291040|201910270900|||||||201910270930||||||||||LAB|F||||
OBX|1|ST|500.3060^TPMT R^TPMT RBC Enzyme Activity Pheno^^21563-2^21563-2|1|8.5^^Y|U/mL RBC|>12.0|L||A^S|F|||201910291133
NTE|1||Falsely low RBC TPMT enzyme activity occurs with patients
NTE|2||who are taking aminosalicylates at the time of the sample
NTE|3||collection.
NTE|4||Low:          <4.0 U/mL RBC
NTE|5||Intermediate:  4.0-12.0 U/mL RBC
NTE|6||Normal:       >12.0 U/mL RBC

MSH|^~\&|LAB|ARH|||201910291135||ORU^R01|4092771|D|2.3|||AL|NE
PID|1||AB00007803|PA2506|LABTEST^ALLOSAURUS^||19851121|F||||||||||AB000896/18|9875619677
OBR|1|34614^LAB|00026600^2810:CE00001R^LAB^281019:CE1^34614|500.3040^TPMTREQ^TPMT RBC Activity PhenoRequest^^XXX-3270^XXX-3270||201910291042|201910280800|||||||201910280815||||||||||LAB|F||||
OBX|1|ST|500.3040^TPMTREQ^TPMT RBC Activity PhenoRequest^^XXX-3270^XXX-3270|1|Approved^^N|||N||A^S|F|||201910291047
OBR|2|34614^LAB|00026600^2810:CE00001R^LAB^281019:CE1^34614|500.3050^TPMT^TPMT RBC Enzyme Activity Pheno^^^21563-2||201910291042|201910280800|||||||201910280815||||||||||LAB|F||||
OBX|1|ST|500.3060^TPMT R^TPMT RBC Enzyme Activity Pheno^^21563-2^21563-2|1|3.9^^Y|U/mL RBC|>12.0|L||A^S|F|||201910291135
NTE|1||Patients with low RBC TPMT enzyme activity are at high risk
NTE|2||of AZA or 6-mercaptopurine induced leucopenia.
NTE|3||Low:          <4.0 U/mL RBC
NTE|4||Intermediate:  4.0-12.0 U/mL RBC
NTE|5||Normal:       >12.0 U/mL RBC